Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linjie Li

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Journal of Medicinal Chemistry|October 14, 2025
Modular PROTAC/IMiD Bifunctional Molecule Design for the Degradation of Synergistic Targets in the Treatment of LymphomaYuheng Jin, Xueyan Liao, Jingyu Zhang, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic functionYuheng Jin, Xuxin Qi, Xiaoli Yu, et al.
Nature Communications|November 3, 2025
SARS-CoV-2 NSP14 inhibitor exhibits potent antiviral activity and reverses NSP14-driven host modulationMengxin Luo, Jun Mo, Ziqiao Wang, et al.
Journal of the American Chemical Society|November 22, 2024
Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Nonstructural Protein InhibitorsXudong Wang, Liwei Xiong, Ying Zhu, et al.
Cell|June 17, 2021
Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other speciesKefang Liu, Xiaoqian Pan, Linjie Li, et al.
British Journal of Haematology|February 24, 2024
Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre studyPeipei Ye, Yixuan Cheng, Jiaying Lian, et al.
Frontiers in Oncology|November 1, 2021
Non-Ablative Chemotherapy Followed by HLA-Mismatched Allogeneic CD3<sup>+</sup> T-Cells Infusion Causes An Augment of T-Cells With Mild CRS: A Multi-Centers Single-Arm Prospective Study on Elderly Acute Myeloid Leukemia and int-2/High Risk Myelodysplastic Syndrome PatientsYan Huang, Minghua Hong, Zhigang Qu, et al.
Atmospheric Chemistry and Physics|August 31, 2021
Atmospheric conditions and composition that influence PM<sub>2.5</sub> oxidative potential in Beijing, ChinaSteven J Campbell, Kate Wolfer, Battist Utinger, et al.
Immunity|July 1, 2022
Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3Min Huang, Lili Wu, Anqi Zheng, et al.
Nature Communications|July 21, 2023
Structural basis for receptor binding and broader interspecies receptor recognition of currently circulating Omicron sub-variantsZhennan Zhao, Yufeng Xie, Bin Bai, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Journal of Medicinal Chemistry|October 14, 2025
Modular PROTAC/IMiD Bifunctional Molecule Design for the Degradation of Synergistic Targets in the Treatment of LymphomaYuheng Jin, Xueyan Liao, Jingyu Zhang, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic functionYuheng Jin, Xuxin Qi, Xiaoli Yu, et al.
Nature Communications|November 3, 2025
SARS-CoV-2 NSP14 inhibitor exhibits potent antiviral activity and reverses NSP14-driven host modulationMengxin Luo, Jun Mo, Ziqiao Wang, et al.
Journal of the American Chemical Society|November 22, 2024
Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Nonstructural Protein InhibitorsXudong Wang, Liwei Xiong, Ying Zhu, et al.
Cell|June 17, 2021
Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other speciesKefang Liu, Xiaoqian Pan, Linjie Li, et al.
British Journal of Haematology|February 24, 2024
Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre studyPeipei Ye, Yixuan Cheng, Jiaying Lian, et al.
Frontiers in Oncology|November 1, 2021
Non-Ablative Chemotherapy Followed by HLA-Mismatched Allogeneic CD3<sup>+</sup> T-Cells Infusion Causes An Augment of T-Cells With Mild CRS: A Multi-Centers Single-Arm Prospective Study on Elderly Acute Myeloid Leukemia and int-2/High Risk Myelodysplastic Syndrome PatientsYan Huang, Minghua Hong, Zhigang Qu, et al.
Atmospheric Chemistry and Physics|August 31, 2021
Atmospheric conditions and composition that influence PM<sub>2.5</sub> oxidative potential in Beijing, ChinaSteven J Campbell, Kate Wolfer, Battist Utinger, et al.
Immunity|July 1, 2022
Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3Min Huang, Lili Wu, Anqi Zheng, et al.
Nature Communications|July 21, 2023
Structural basis for receptor binding and broader interspecies receptor recognition of currently circulating Omicron sub-variantsZhennan Zhao, Yufeng Xie, Bin Bai, et al.
Pageof 20